Top Tech Companies (4,167)
Don't see your company?
Create a company profile
Mason is the fastest way to take smart devices from idea to end user. Whether building a single-use device from scratch or scaling a line of smart products, with Mason it’s faster and less costly to build, deploy and scale. The Mason Smart Device Platform is the only fully managed infrastructure for developing and delivering dedicated devices. It offers flexible usage-based pricing for fleets of devices and manages the underlying complexity of all associated backend services, making software delivery on a smart product line—whether it’s a tablet, wearable or new form factor—as simple as delivering software in the cloud. This frees innovators to focus on what matters: application development, feature specification and UX. Granular access to add, remove or lock down capabilities makes it possible for highly customized products to be built as envisioned. Mason offloads hardware investment risks and logistics, including inventory procurement, warehousing and supply chain management. With options like zero-touch provisioning, devices can work perfectly out of the box without end user intervention. Remote fleet management, troubleshooting and automated software updates by Mason ensure security and positive end user experiences. Organizations of all sizes rely on Mason to bring innovations and hundreds of use cases to market without reinventing the wheel. Smarter from start to finish with Mason.™ LEARN MORE about building with Mason: https://www.youtube.com/channel/UCHTCSmQxIMmxCj1zL1EXNkA AWARDS * 2023: Best Places to Work & Best Startups to Work For, Built In Seattle * 2022: Best Places to Work & Best Small Companies to Work For, Built In Seattle * 2022: IoT Health & Wellness Innovation of the Year, IoT Breakthrough * 2021: Deloitte Technology Fast 500™, Deloitte * 2019: Tech Impact Awards, Mobile - Silver, Seattle Business magazine Follow us on LinkedIn | https://www.linkedin.com/company/mason-america/
Peter Attia, M.D. is a Stanford, John Hopkins, and NIH-trained physician focused on the applied science of longevity. For the past 10 years, Peter and his team of experts have devoted their lives to demystifying the science of longevity. Through private practice, his team has helped patients navigate the latest research on longevity and put it into action. Peter and his team are now opening up and sharing these insights with you.
Auris Health was acquired by Ethicon, part of the Johnson & Johnson Medical Devices Companies, in 2019. Based in Silicon Valley, Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive techniques, and create new categories of care that redefine optimal patient outcomes. The company is committed to transforming medical intervention by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform. Every element of our technology is driven by patient-specific design aimed at maintaining the integrity of the human body.
Articulate Labs has developed wearable technology that turns everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning. The first target market for this technology is the $5B knee treatment market. Here, our device (KneeStim) will enable mobile quadriceps strengthening and re-education for the 14M+ seeking conservative, cost- and time-efficient knee treatment. Company status: * Working prototype * Feasibility study conducted * Four patents issued; two pending * Independent market validation with likely prescribers * Regulatory pathway established * Reimbursement codes identified This device has not yet been cleared by the FDA for marketing, and all above statements are prospective.
We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Once infused into patients, this population of T cells attacks multiple tumor targets and acts to activate the patient’s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, its products (i) are significantly less expensive and easier to manufacture, (ii) appear to be markedly less toxic, and (iii) are associated with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling therapeutic product profile, as compared to current gene-modified CAR-T and TCR-based therapies. Marker is also advancing a number of innovative peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including our Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and our HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In parallel, we are developing a proprietary DNA expression technology named PolyStart™ to improve the ability of the cellular immune system to recognize and destroy diseased cells.
Plant Health Care is a leading provider of scientifically proven biological products for the agricultural industry.
As the leader in Workforce Wearables, our mission at MakuSafe is to make the world safer through technology and data. Smart. Safe. MākuSafe. MākuSafe is an Insurtech SaaS/Data & Analytics company based in America's Heartland. Our mission is to improve worker health, safety, and productivity while reducing worker compensation claims and mitigating workplace risks. Founded in 2016, MākuSafe has developed proprietary wearable technology that gathers real-time environmental and motion data from workers. Patents pending. Our cloud platform, MākuSmart, then uses machine learning to identify high-risk trends in the facility. The portal auto-records near-misses, proactively targets resources to specific conditions & occurrences, and streamlines compliance reporting. Our true insurtech solution is being beta tested in several midwest manufacturing, agriculture, and logistics facilities. Be sure to catch our latest news, announcements, and more info at makusafe.com!
Provider of LIMS and ELN Solutions
Moxe Health provides a clinical data clearinghouse, focused on accelerating the exchange of clinical data from all corners of the healthcare ecosystem. With a team of experienced, passionate EHR experts who understand data integration challenges, Moxe helps health systems, health plans, and HIT vendors work together.
PierianDx is catalyzing global adoption of genomic sequencing in healthcare
NeoCardial Technologies™ is dedicated to helping this underserved patient group lead a normal, healthy and long life.
Medica is a non-profit health plan that serves communities in Minnesota, Iowa, Kansas, Missouri, Nebraska, North Dakota, Oklahoma, South Dakota and Wisconsin — the heart of America. As a company, we empower communities by listening to their voices, learning about community needs, and devoting time and resources to help. Medica partners with the communities it serves in many ways, including the Medica Foundation, a nonprofit, charitable grant-making foundation. The Medica Foundation, which provides more than $1 million in grants annually, generally seeks to fund community-based programs and initiatives that can provide sustainable, measurable improvements in the availability, access and quality of health care. Mission To be the trusted health plan of choice for customers, members, partners and our employees. Vision To be trusted in the community for our unwavering commitment to high quality, affordable health care. Values Customer Focus Excellence Stewardship Integrity Diversity
REMSleep Holdings is a design & manufacture devices its products for the treatment of sleep apnea and other respiratory conditions.
There is an inflection point happening right before our eyes in healthcare. In 2019, only 8% of patients had tried telehealth. Today, the pandemic has brought the future faster than anyone could have ever imagined. Now, a staggering 80% of patients plan to use telehealth. But there is a huge problem - over 70% of medical conditions still require going to a laboratory and virtual care has no way to reach these patients in-person.
Kinship is here to help everyone pet parent like a pro. Why? Because our pets make us better humans, and we owe them the best possible care. As the premier partner to a new generation of pet parents, we use our data, products, and services to help people be the best pet parents they can be. And we unite changemakers in pet care to break down barriers, open new doors, share insights, and advance our collective knowledge. All so we can reimagine the pet parenting experience, up people’s confidence, and help the world find better ways to care. Kinship is a coalition that includes: Adopt-a-Pet, the destination for finding homes for homeless pets The Wildest, the destination that helps pet parents keep their cool in the wild world of pet parenting The Kin, our mobile application that houses everything a pet parent needs to care for their pet and live their best lives together. The app brings together the three Kinship consumer brands and matches pet needs to quality service providers, helps them book and share necessary records, and provides personalized content so pet parents can parent with ease and confidence. PetExec, a B2B (SaaS) digital operations manager and the world's leading tool for petcare businesses. Together, these teams and more work to set new standards in pet care. And, as a part of Mars Petcare, they work to create a better world for pets. Learn more at www.kinship.co.
The National Association of County and City Health Officials (NACCHO) is the national organization representing local health departments. NACCHO supports efforts that protect and improve the health of all people and all communities by promoting national policy, developing resources and programs, seeking health equity, and supporting effective local public health practice and systems.
Olio is the only collaboration platform to digitally connect acute and post-acute providers by specialty.
Evoke Pharma develops therapeutics for the treatment of gastrointestinal diseases.
Sovereign Pharmaceuticals is a capable, nimble Contract Development Manufacturing Organization (CDMO) focused on the customer and committed to exceeding regulatory and quality requirements through motivated, empowered, and dedicated employees. Sovereign covers formulation development, clinical trials, QA, regulatory, solid dose manufacturing, liquid manufacturing, and everything in between. We've got you covered.
Egg Medical is a medical device company that offers EGGNEST, a passive protection designed to drastically reduce scatter radiation exposure.
